APO Research

APO RESEARCH · REPORT

Custom Recombinant Antibody Production Service

Selected research

Market Structure

Global Custom Recombinant Antibody Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Custom Recombinant Antibody Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Custom Recombinant Antibody Production Service include RayBiotech, Cygnus Technologies, Cayman Chemical, Boster Bio, Bon Opus Biosciences, Biomatik, Abcam, Bio-Rad and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Custom Recombinant Antibody Production Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Recombinant Antibody Production Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Recombinant Antibody Production Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Custom Recombinant Antibody Production Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Custom Recombinant Antibody Production Service Segment by Company

RayBiotech

Cygnus Technologies

Cayman Chemical

Boster Bio

Bon Opus Biosciences

Biomatik

Abcam

Bio-Rad

Creative Biolabs

ProteoGenix

Sino Biological

Absolute Antibody

ProMab Biotechnologies

ACROBiosystems

Cusabio Technology

Covance

evitria

ProSci

GenScript

Custom Recombinant Antibody Production Service Segment by Type

Monoclonal Antibody (mAb) Production

Polyclonal Antibody (pAb) Production

Custom Recombinant Antibody Production Service Segment by Application

Pharmaceutics

Scientific Research

Others

Custom Recombinant Antibody Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Recombinant Antibody Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Recombinant Antibody Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Recombinant Antibody Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Custom Recombinant Antibody Production Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Recombinant Antibody Production Service industry.

Chapter 3: Detailed analysis of Custom Recombinant Antibody Production Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Recombinant Antibody Production Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monoclonal Antibody (mAb) Production Table 3. Key Players of Polyclonal Antibody (pAb) Production Table 4. Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutics Table 6. Key Players of Scientific Research Table 7. Key Players of Others Table 8. Global Custom Recombinant Antibody Production Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Custom Recombinant Antibody Production Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Custom Recombinant Antibody Production Service Market Share by Region (2021-2026) Table 11. Global Custom Recombinant Antibody Production Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Custom Recombinant Antibody Production Service Market Share by Region (2027-2032) Table 13. Custom Recombinant Antibody Production Service Industry Trends Table 14. Custom Recombinant Antibody Production Service Industry Drivers Table 15. Custom Recombinant Antibody Production Service Industry Opportunities and Challenges Table 16. Custom Recombinant Antibody Production Service Industry Restraints Table 17. Global Custom Recombinant Antibody Production Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Custom Recombinant Antibody Production Service Revenue Market Share by Company (2021-2026) Table 19. Global Custom Recombinant Antibody Production Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Custom Recombinant Antibody Production Service Key Company Head Office and Area Served Table 21. Global Custom Recombinant Antibody Production Service Company, Product Type & Application Table 22. Global Custom Recombinant Antibody Production Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Custom Recombinant Antibody Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Custom Recombinant Antibody Production Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Custom Recombinant Antibody Production Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Custom Recombinant Antibody Production Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Custom Recombinant Antibody Production Service Revenue Market Share by Type (2021-2026) Table 29. Global Custom Recombinant Antibody Production Service Revenue Market Share by Type (2027-2032) Table 30. Global Custom Recombinant Antibody Production Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Custom Recombinant Antibody Production Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Custom Recombinant Antibody Production Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Custom Recombinant Antibody Production Service Revenue Market Share by Application (2021-2026) Table 34. Global Custom Recombinant Antibody Production Service Revenue Market Share by Application (2027-2032) Table 35. RayBiotech Company Information Table 36. RayBiotech Business Overview Table 37. RayBiotech Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. RayBiotech Custom Recombinant Antibody Production Service Product Portfolio Table 39. RayBiotech Recent Development Table 40. Cygnus Technologies Company Information Table 41. Cygnus Technologies Business Overview Table 42. Cygnus Technologies Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Cygnus Technologies Custom Recombinant Antibody Production Service Product Portfolio Table 44. Cygnus Technologies Recent Development Table 45. Cayman Chemical Company Information Table 46. Cayman Chemical Business Overview Table 47. Cayman Chemical Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Cayman Chemical Custom Recombinant Antibody Production Service Product Portfolio Table 49. Cayman Chemical Recent Development Table 50. Boster Bio Company Information Table 51. Boster Bio Business Overview Table 52. Boster Bio Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Boster Bio Custom Recombinant Antibody Production Service Product Portfolio Table 54. Boster Bio Recent Development Table 55. Bon Opus Biosciences Company Information Table 56. Bon Opus Biosciences Business Overview Table 57. Bon Opus Biosciences Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bon Opus Biosciences Custom Recombinant Antibody Production Service Product Portfolio Table 59. Bon Opus Biosciences Recent Development Table 60. Biomatik Company Information Table 61. Biomatik Business Overview Table 62. Biomatik Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Biomatik Custom Recombinant Antibody Production Service Product Portfolio Table 64. Biomatik Recent Development Table 65. Abcam Company Information Table 66. Abcam Business Overview Table 67. Abcam Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Abcam Custom Recombinant Antibody Production Service Product Portfolio Table 69. Abcam Recent Development Table 70. Bio-Rad Company Information Table 71. Bio-Rad Business Overview Table 72. Bio-Rad Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bio-Rad Custom Recombinant Antibody Production Service Product Portfolio Table 74. Bio-Rad Recent Development Table 75. Creative Biolabs Company Information Table 76. Creative Biolabs Business Overview Table 77. Creative Biolabs Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Creative Biolabs Custom Recombinant Antibody Production Service Product Portfolio Table 79. Creative Biolabs Recent Development Table 80. ProteoGenix Company Information Table 81. ProteoGenix Business Overview Table 82. ProteoGenix Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. ProteoGenix Custom Recombinant Antibody Production Service Product Portfolio Table 84. ProteoGenix Recent Development Table 85. Sino Biological Company Information Table 86. Sino Biological Business Overview Table 87. Sino Biological Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Sino Biological Custom Recombinant Antibody Production Service Product Portfolio Table 89. Sino Biological Recent Development Table 90. Absolute Antibody Company Information Table 91. Absolute Antibody Business Overview Table 92. Absolute Antibody Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Absolute Antibody Custom Recombinant Antibody Production Service Product Portfolio Table 94. Absolute Antibody Recent Development Table 95. ProMab Biotechnologies Company Information Table 96. ProMab Biotechnologies Business Overview Table 97. ProMab Biotechnologies Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. ProMab Biotechnologies Custom Recombinant Antibody Production Service Product Portfolio Table 99. ProMab Biotechnologies Recent Development Table 100. ACROBiosystems Company Information Table 101. ACROBiosystems Business Overview Table 102. ACROBiosystems Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. ACROBiosystems Custom Recombinant Antibody Production Service Product Portfolio Table 104. ACROBiosystems Recent Development Table 105. Cusabio Technology Company Information Table 106. Cusabio Technology Business Overview Table 107. Cusabio Technology Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Cusabio Technology Custom Recombinant Antibody Production Service Product Portfolio Table 109. Cusabio Technology Recent Development Table 110. Covance Company Information Table 111. Covance Business Overview Table 112. Covance Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Covance Custom Recombinant Antibody Production Service Product Portfolio Table 114. Covance Recent Development Table 115. evitria Company Information Table 116. evitria Business Overview Table 117. evitria Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. evitria Custom Recombinant Antibody Production Service Product Portfolio Table 119. evitria Recent Development Table 120. ProSci Company Information Table 121. ProSci Business Overview Table 122. ProSci Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. ProSci Custom Recombinant Antibody Production Service Product Portfolio Table 124. ProSci Recent Development Table 125. GenScript Company Information Table 126. GenScript Business Overview Table 127. GenScript Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. GenScript Custom Recombinant Antibody Production Service Product Portfolio Table 129. GenScript Recent Development Table 130. North America Custom Recombinant Antibody Production Service Market Size by Type (2021-2026) & (US$ Million) Table 131. North America Custom Recombinant Antibody Production Service Market Size by Type (2027-2032) & (US$ Million) Table 132. North America Custom Recombinant Antibody Production Service Market Size by Application (2021-2026) & (US$ Million) Table 133. North America Custom Recombinant Antibody Production Service Market Size by Application (2027-2032) & (US$ Million) Table 134. North America Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Custom Recombinant Antibody Production Service Market Size by Country (2021-2026) Table 136. North America Custom Recombinant Antibody Production Service Market Size by Country (2027-2032) Table 137. Europe Custom Recombinant Antibody Production Service Market Size by Type (2021-2026) & (US$ Million) Table 138. Europe Custom Recombinant Antibody Production Service Market Size by Type (2027-2032) & (US$ Million) Table 139. Europe Custom Recombinant Antibody Production Service Market Size by Application (2021-2026) & (US$ Million) Table 140. Europe Custom Recombinant Antibody Production Service Market Size by Application (2027-2032) & (US$ Million) Table 141. Europe Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Custom Recombinant Antibody Production Service Market Size by Country (2021-2026) Table 143. Europe Custom Recombinant Antibody Production Service Market Size by Country (2027-2032) Table 144. China Custom Recombinant Antibody Production Service Market Size by Type (2021-2026) & (US$ Million) Table 145. China Custom Recombinant Antibody Production Service Market Size by Type (2027-2032) & (US$ Million) Table 146. China Custom Recombinant Antibody Production Service Market Size by Application (2021-2026) & (US$ Million) Table 147. China Custom Recombinant Antibody Production Service Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Custom Recombinant Antibody Production Service Market Size by Type (2021-2026) & (US$ Million) Table 149. Asia Custom Recombinant Antibody Production Service Market Size by Type (2027-2032) & (US$ Million) Table 150. Asia Custom Recombinant Antibody Production Service Market Size by Application (2021-2026) & (US$ Million) Table 151. Asia Custom Recombinant Antibody Production Service Market Size by Application (2027-2032) & (US$ Million) Table 152. Asia Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Custom Recombinant Antibody Production Service Market Size by Country (2021-2026) Table 154. Asia Custom Recombinant Antibody Production Service Market Size by Country (2027-2032) Table 155. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Type (2021-2026) & (US$ Million) Table 156. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Type (2027-2032) & (US$ Million) Table 157. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Application (2021-2026) & (US$ Million) Table 158. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Application (2027-2032) & (US$ Million) Table 159. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2021-2026) Table 161. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Custom Recombinant Antibody Production Service Product Image Figure 2. Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Custom Recombinant Antibody Production Service Market Share by Type: 2025 VS 2032 Figure 4. Monoclonal Antibody (mAb) Production Image Figure 5. Polyclonal Antibody (pAb) Production Image Figure 6. Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Custom Recombinant Antibody Production Service Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceutics Image Figure 9. Scientific Research Image Figure 10. Others Image Figure 11. Global Custom Recombinant Antibody Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 13. Global Custom Recombinant Antibody Production Service Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Custom Recombinant Antibody Production Service Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Custom Recombinant Antibody Production Service Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Custom Recombinant Antibody Production Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Custom Recombinant Antibody Production Service Revenue Market Share by Type (2021-2032) Figure 20. Global Custom Recombinant Antibody Production Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Custom Recombinant Antibody Production Service Revenue Market Share by Application (2021-2032) Figure 22. North America Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 23. North America Custom Recombinant Antibody Production Service Market Share by Type (2021-2032) Figure 24. North America Custom Recombinant Antibody Production Service Market Share by Application (2021-2032) Figure 25. North America Custom Recombinant Antibody Production Service Market Share by Country (2021-2032) Figure 26. United States Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 27. Canada Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 29. Europe Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 30. Europe Custom Recombinant Antibody Production Service Market Share by Type (2021-2032) Figure 31. Europe Custom Recombinant Antibody Production Service Market Share by Application (2021-2032) Figure 32. Europe Custom Recombinant Antibody Production Service Market Share by Country (2021-2032) Figure 33. Germany Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 34. France Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 36. Italy Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 37. Russia Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 39. China Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 40. China Custom Recombinant Antibody Production Service Market Share by Type (2021-2032) Figure 41. China Custom Recombinant Antibody Production Service Market Share by Application (2021-2032) Figure 42. Asia Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 43. Asia Custom Recombinant Antibody Production Service Market Share by Type (2021-2032) Figure 44. Asia Custom Recombinant Antibody Production Service Market Share by Application (2021-2032) Figure 45. Asia Custom Recombinant Antibody Production Service Market Share by Country (2021-2032) Figure 46. Japan Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 50. India Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 51. Australia Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Share by Country (2021-2032) Figure 56. Brazil Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 61. UAE Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 63. Chile Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibody (mAb) Production
  • Polyclonal Antibody (pAb) Production
Applications
  • Pharmaceutics
  • Scientific Research
  • Others
Companies covered
  • RayBiotech
  • Cygnus Technologies
  • Cayman Chemical
  • Boster Bio
  • Bon Opus Biosciences
  • Biomatik
  • Abcam
  • Bio-Rad
  • Creative Biolabs
  • ProteoGenix
  • Sino Biological
  • Absolute Antibody
  • ProMab Biotechnologies
  • ACROBiosystems
  • Cusabio Technology
  • Covance
  • evitria
  • ProSci
  • GenScript

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibody (mAb) Production
  5. 1.2.3 Polyclonal Antibody (pAb) Production
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutics
  9. 1.3.3 Scientific Research
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Custom Recombinant Antibody Production Service Growth Trends by Region
  13. 1.5.1 Global Custom Recombinant Antibody Production Service Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Custom Recombinant Antibody Production Service Market Size by Region (2021-2026)
  15. 1.5.3 Custom Recombinant Antibody Production Service Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Custom Recombinant Antibody Production Service Market Dynamics
  1. 2.1 Custom Recombinant Antibody Production Service Industry Trends
  2. 2.2 Custom Recombinant Antibody Production Service Industry Drivers
  3. 2.3 Custom Recombinant Antibody Production Service Industry Opportunities and Challenges
  4. 2.4 Custom Recombinant Antibody Production Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Custom Recombinant Antibody Production Service Revenue by Company (2021-2026)
  2. 3.2 Global Custom Recombinant Antibody Production Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Custom Recombinant Antibody Production Service Key Company Head office and Area Served
  4. 3.4 Global Custom Recombinant Antibody Production Service Company, Product Type & Application
  5. 3.5 Global Custom Recombinant Antibody Production Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Custom Recombinant Antibody Production Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Custom Recombinant Antibody Production Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Custom Recombinant Antibody Production Service Tier 1, Tier 2, and Tier 3
4 Custom Recombinant Antibody Production Service Market by Type
  1. 4.1 Global Custom Recombinant Antibody Production Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Custom Recombinant Antibody Production Service Market Size by Type (2021-2032)
  3. 4.3 Global Custom Recombinant Antibody Production Service Market Size Share by Type (2021-2032)
5 Custom Recombinant Antibody Production Service Market by Application
  1. 5.1 Global Custom Recombinant Antibody Production Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Recombinant Antibody Production Service Market Size by Application (2021-2032)
  3. 5.3 Global Custom Recombinant Antibody Production Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 RayBiotech
  2. 6.1.1 RayBiotech Company Information
  3. 6.1.2 RayBiotech Business Overview
  4. 6.1.3 RayBiotech Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 RayBiotech Custom Recombinant Antibody Production Service Product Portfolio
  6. 6.1.5 RayBiotech Recent Developments
  7. 6.2 Cygnus Technologies
  8. 6.2.1 Cygnus Technologies Company Information
  9. 6.2.2 Cygnus Technologies Business Overview
  10. 6.2.3 Cygnus Technologies Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cygnus Technologies Custom Recombinant Antibody Production Service Product Portfolio
  12. 6.2.5 Cygnus Technologies Recent Developments
  13. 6.3 Cayman Chemical
  14. 6.3.1 Cayman Chemical Company Information
  15. 6.3.2 Cayman Chemical Business Overview
  16. 6.3.3 Cayman Chemical Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Cayman Chemical Custom Recombinant Antibody Production Service Product Portfolio
  18. 6.3.5 Cayman Chemical Recent Developments
  19. 6.4 Boster Bio
  20. 6.4.1 Boster Bio Company Information
  21. 6.4.2 Boster Bio Business Overview
  22. 6.4.3 Boster Bio Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Boster Bio Custom Recombinant Antibody Production Service Product Portfolio
  24. 6.4.5 Boster Bio Recent Developments
  25. 6.5 Bon Opus Biosciences
  26. 6.5.1 Bon Opus Biosciences Company Information
  27. 6.5.2 Bon Opus Biosciences Business Overview
  28. 6.5.3 Bon Opus Biosciences Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bon Opus Biosciences Custom Recombinant Antibody Production Service Product Portfolio
  30. 6.5.5 Bon Opus Biosciences Recent Developments
  31. 6.6 Biomatik
  32. 6.6.1 Biomatik Company Information
  33. 6.6.2 Biomatik Business Overview
  34. 6.6.3 Biomatik Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Biomatik Custom Recombinant Antibody Production Service Product Portfolio
  36. 6.6.5 Biomatik Recent Developments
  37. 6.7 Abcam
  38. 6.7.1 Abcam Company Information
  39. 6.7.2 Abcam Business Overview
  40. 6.7.3 Abcam Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Abcam Custom Recombinant Antibody Production Service Product Portfolio
  42. 6.7.5 Abcam Recent Developments
  43. 6.8 Bio-Rad
  44. 6.8.1 Bio-Rad Company Information
  45. 6.8.2 Bio-Rad Business Overview
  46. 6.8.3 Bio-Rad Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bio-Rad Custom Recombinant Antibody Production Service Product Portfolio
  48. 6.8.5 Bio-Rad Recent Developments
  49. 6.9 Creative Biolabs
  50. 6.9.1 Creative Biolabs Company Information
  51. 6.9.2 Creative Biolabs Business Overview
  52. 6.9.3 Creative Biolabs Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Creative Biolabs Custom Recombinant Antibody Production Service Product Portfolio
  54. 6.9.5 Creative Biolabs Recent Developments
  55. 6.10 ProteoGenix
  56. 6.10.1 ProteoGenix Company Information
  57. 6.10.2 ProteoGenix Business Overview
  58. 6.10.3 ProteoGenix Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ProteoGenix Custom Recombinant Antibody Production Service Product Portfolio
  60. 6.10.5 ProteoGenix Recent Developments
  61. 6.11 Sino Biological
  62. 6.11.1 Sino Biological Company Information
  63. 6.11.2 Sino Biological Business Overview
  64. 6.11.3 Sino Biological Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sino Biological Custom Recombinant Antibody Production Service Product Portfolio
  66. 6.11.5 Sino Biological Recent Developments
  67. 6.12 Absolute Antibody
  68. 6.12.1 Absolute Antibody Company Information
  69. 6.12.2 Absolute Antibody Business Overview
  70. 6.12.3 Absolute Antibody Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Absolute Antibody Custom Recombinant Antibody Production Service Product Portfolio
  72. 6.12.5 Absolute Antibody Recent Developments
  73. 6.13 ProMab Biotechnologies
  74. 6.13.1 ProMab Biotechnologies Company Information
  75. 6.13.2 ProMab Biotechnologies Business Overview
  76. 6.13.3 ProMab Biotechnologies Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 ProMab Biotechnologies Custom Recombinant Antibody Production Service Product Portfolio
  78. 6.13.5 ProMab Biotechnologies Recent Developments
  79. 6.14 ACROBiosystems
  80. 6.14.1 ACROBiosystems Company Information
  81. 6.14.2 ACROBiosystems Business Overview
  82. 6.14.3 ACROBiosystems Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 ACROBiosystems Custom Recombinant Antibody Production Service Product Portfolio
  84. 6.14.5 ACROBiosystems Recent Developments
  85. 6.15 Cusabio Technology
  86. 6.15.1 Cusabio Technology Company Information
  87. 6.15.2 Cusabio Technology Business Overview
  88. 6.15.3 Cusabio Technology Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Cusabio Technology Custom Recombinant Antibody Production Service Product Portfolio
  90. 6.15.5 Cusabio Technology Recent Developments
  91. 6.16 Covance
  92. 6.16.1 Covance Company Information
  93. 6.16.2 Covance Business Overview
  94. 6.16.3 Covance Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Covance Custom Recombinant Antibody Production Service Product Portfolio
  96. 6.16.5 Covance Recent Developments
  97. 6.17 evitria
  98. 6.17.1 evitria Company Information
  99. 6.17.2 evitria Business Overview
  100. 6.17.3 evitria Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 evitria Custom Recombinant Antibody Production Service Product Portfolio
  102. 6.17.5 evitria Recent Developments
  103. 6.18 ProSci
  104. 6.18.1 ProSci Company Information
  105. 6.18.2 ProSci Business Overview
  106. 6.18.3 ProSci Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 ProSci Custom Recombinant Antibody Production Service Product Portfolio
  108. 6.18.5 ProSci Recent Developments
  109. 6.19 GenScript
  110. 6.19.1 GenScript Company Information
  111. 6.19.2 GenScript Business Overview
  112. 6.19.3 GenScript Custom Recombinant Antibody Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 GenScript Custom Recombinant Antibody Production Service Product Portfolio
  114. 6.19.5 GenScript Recent Developments
7 North America
  1. 7.1 North America Custom Recombinant Antibody Production Service Market Size (2021-2032)
  2. 7.2 North America Custom Recombinant Antibody Production Service Market Size by Type
  3. 7.2.1 North America Custom Recombinant Antibody Production Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Custom Recombinant Antibody Production Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Custom Recombinant Antibody Production Service Market Share by Type (2021-2032)
  6. 7.3 North America Custom Recombinant Antibody Production Service Market Size by Application
  7. 7.3.1 North America Custom Recombinant Antibody Production Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Custom Recombinant Antibody Production Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Custom Recombinant Antibody Production Service Market Share by Application (2021-2032)
  10. 7.4 North America Custom Recombinant Antibody Production Service Market Size by Country
  11. 7.4.1 North America Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Custom Recombinant Antibody Production Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Custom Recombinant Antibody Production Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Custom Recombinant Antibody Production Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Custom Recombinant Antibody Production Service Market Size (2021-2032)
  2. 8.2 Europe Custom Recombinant Antibody Production Service Market Size by Type
  3. 8.2.1 Europe Custom Recombinant Antibody Production Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Custom Recombinant Antibody Production Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Custom Recombinant Antibody Production Service Market Share by Type (2021-2032)
  6. 8.3 Europe Custom Recombinant Antibody Production Service Market Size by Application
  7. 8.3.1 Europe Custom Recombinant Antibody Production Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Custom Recombinant Antibody Production Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Custom Recombinant Antibody Production Service Market Share by Application (2021-2032)
  10. 8.4 Europe Custom Recombinant Antibody Production Service Market Size by Country
  11. 8.4.1 Europe Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Custom Recombinant Antibody Production Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Custom Recombinant Antibody Production Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Custom Recombinant Antibody Production Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Custom Recombinant Antibody Production Service Market Size (2021-2032)
  2. 9.2 China Custom Recombinant Antibody Production Service Market Size by Type
  3. 9.2.1 China Custom Recombinant Antibody Production Service Market Size by Type (2021-2026)
  4. 9.2.2 China Custom Recombinant Antibody Production Service Market Size by Type (2027-2032)
  5. 9.2.3 China Custom Recombinant Antibody Production Service Market Share by Type (2021-2032)
  6. 9.3 China Custom Recombinant Antibody Production Service Market Size by Application
  7. 9.3.1 China Custom Recombinant Antibody Production Service Market Size by Application (2021-2026)
  8. 9.3.2 China Custom Recombinant Antibody Production Service Market Size by Application (2027-2032)
  9. 9.3.3 China Custom Recombinant Antibody Production Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Custom Recombinant Antibody Production Service Market Size (2021-2032)
  2. 10.2 Asia Custom Recombinant Antibody Production Service Market Size by Type
  3. 10.2.1 Asia Custom Recombinant Antibody Production Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Custom Recombinant Antibody Production Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Custom Recombinant Antibody Production Service Market Share by Type (2021-2032)
  6. 10.3 Asia Custom Recombinant Antibody Production Service Market Size by Application
  7. 10.3.1 Asia Custom Recombinant Antibody Production Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Custom Recombinant Antibody Production Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Custom Recombinant Antibody Production Service Market Share by Application (2021-2032)
  10. 10.4 Asia Custom Recombinant Antibody Production Service Market Size by Country
  11. 10.4.1 Asia Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Custom Recombinant Antibody Production Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Custom Recombinant Antibody Production Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Custom Recombinant Antibody Production Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Custom Recombinant Antibody Production Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research